These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15464452)

  • 1. New therapies for muscular dystrophy: cautious optimism.
    Cossu G; Sampaolesi M
    Trends Mol Med; 2004 Oct; 10(10):516-20. PubMed ID: 15464452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging strategies for cell and gene therapy of the muscular dystrophies.
    Muir LA; Chamberlain JS
    Expert Rev Mol Med; 2009 Jun; 11():e18. PubMed ID: 19555515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic strategy for muscular dystrophies].
    Shin JH; Takeda S
    Brain Nerve; 2007 Apr; 59(4):415-24. PubMed ID: 17447528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.
    Rodrigues M; Yokota T
    Methods Mol Biol; 2018; 1828():31-55. PubMed ID: 30171533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic and genetic therapy for childhood muscular dystrophies.
    Escolar DM; Scacheri CG
    Curr Neurol Neurosci Rep; 2001 Mar; 1(2):168-74. PubMed ID: 11898513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for muscular dystrophy: moving the field forward.
    Al-Zaidy S; Rodino-Klapac L; Mendell JR
    Pediatr Neurol; 2014 Nov; 51(5):607-18. PubMed ID: 25439576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining stem cells and exon skipping strategy to treat muscular dystrophy.
    Meregalli M; Farini A; Torrente Y
    Expert Opin Biol Ther; 2008 Aug; 8(8):1051-61. PubMed ID: 18613758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of muscular dystrophies.
    Kingston WJ; Moxley RT
    Gen Pharmacol; 1989; 20(3):263-8. PubMed ID: 2663627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy in large animal models of muscular dystrophy.
    Wang Z; Chamberlain JS; Tapscott SJ; Storb R
    ILAR J; 2009; 50(2):187-98. PubMed ID: 19293461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy.
    Durbeej M; Sawatzki SM; Barresi R; Schmainda KM; Allamand V; Michele DE; Campbell KP
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8910-5. PubMed ID: 12851463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental and therapeutic approaches to muscular dystrophies.
    Skuk D; Vilquin JT; Tremblay JP
    Curr Opin Neurol; 2002 Oct; 15(5):563-9. PubMed ID: 12352000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for muscular dystrophy: molecular medicines entering the clinic.
    Bushby K; Lochmüller H; Lynn S; Straub V
    Lancet; 2009 Nov; 374(9704):1849-56. PubMed ID: 19944865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy of Duchenne muscular dystrophy.
    Fassati A; Murphy S; Dickson G
    Adv Genet; 1997; 35():117-53. PubMed ID: 9348647
    [No Abstract]   [Full Text] [Related]  

  • 14. The physiological evaluation of gene therapies of dystrophin-deficient muscles.
    Gillis JM; Deconinck N
    Adv Exp Med Biol; 1998; 453():411-6; discussion 417. PubMed ID: 9889852
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapies in muscular dystrophy: current concepts and future prospects.
    Urtizberea JA
    Eur Neurol; 2000; 43(3):127-32. PubMed ID: 10765050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies.
    Abati E; Sclarandi E; Comi GP; Parente V; Corti S
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Strategies of Muscular Dystrophy Therapeutics: An Overview.
    Lim KRQ; Yokota T
    Methods Mol Biol; 2023; 2587():3-30. PubMed ID: 36401021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide-mediated gene therapy for muscular dystrophies.
    Rando TA
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S55-60. PubMed ID: 12206797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoblast transfer therapy: is there any light at the end of the tunnel?
    Mouly V; Aamiri A; Périé S; Mamchaoui K; Barani A; Bigot A; Bouazza B; François V; Furling D; Jacquemin V; Negroni E; Riederer I; Vignaud A; St Guily JL; Butler-Browne GS
    Acta Myol; 2005 Oct; 24(2):128-33. PubMed ID: 16550930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
    Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
    Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.